The associations between the presence of mutations in these 12 genes and clinical variables of the patients, including tumor characteristics, were evaluated, and CDKN2A, EGFR, MLH1, NFE2L2, PTEN, TP53, and VHL were found to be associated with several clinical parameters (Supplementary Table S2). This evidence concerns the gene NFE2L2 and neoplasm.